Brief: Tenax Therapeutics Q2 Net Income USD -17.803 Million
BRIEF-Tenax Therapeutics Q2 Net Income USD -17.803 Million Jul 31 (Reuters) - Tenax Therapeutics Q2 operating expenses USD 18.784 million.
- Q2 operating income USD -18.784 million
BRIEF-Tenax Therapeutics Q2 Net Income USD -17.803 Million Jul 31 (Reuters) - Tenax Therapeutics Q2 operating expenses USD 18.784 million.